| Medical and Health Sciences | Lifetime | 179 | US 98 | 99.99 |
| Economics and Finance | Lifetime | 662 | US 383 | 99.56 |
| Medical and Health Sciences | 2021-2025 | 258 | US 91 | 99.95 |
| Economics and Finance | 2021-2025 | 501 | US 118 | 98.17 |
| Cardiology and Cardiovascular Medicine | Lifetime | 39 | US 26 | 99.96 |
| Surgery | Lifetime | 347 | US 193 | 99.70 |
| Econometrics and Quantitative Economics | Lifetime | 359 | US 219 | 99.62 |
| Radiology, Nuclear Medicine and Imaging | Lifetime | 170 | US 101 | 99.58 |
| General Health Professions | Lifetime | 791 | US 409 | 99.10 |
| Emergency Medicine | Lifetime | 203 | US 114 | 98.43 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 719 | US 383 | 97.53 |
| Family Practice | Lifetime | 129 | US 65 | 92.23 |
| Nephrology | Lifetime | 890 | US 399 | 84.73 |
| Geriatrics and Gerontology | Lifetime | 495 | US 191 | 80.80 |
| Cardiology and Cardiovascular Medicine | 2021-2025 | 54 | US 33 | 99.79 |
| Surgery | 2021-2025 | 245 | US 99 | 98.44 |
| Econometrics and Quantitative Economics | 2021-2025 | 354 | US 62 | 98.20 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 243 | US 85 | 95.49 |
| General Health Professions | 2021-2025 | 970 | US 336 | 91.83 |
| Emergency Medicine | 2021-2025 | 200 | US 89 | 88.47 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 401 | US 158 | 88.94 |
| Cardiac Health and Mental Health | Lifetime | 4 | US 2 | 99.91 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 16 | US 10 | 99.90 |
| Cardiac Imaging and Diagnostics | Lifetime | 28 | US 18 | 99.93 |
| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 30 | US 15 | 99.86 |
| Acute Myocardial Infarction Research | Lifetime | 23 | US 15 | 99.91 |
| Heart Failure Treatment and Management | Lifetime | 28 | US 17 | 99.89 |
| Cardiovascular Function and Risk Factors | Lifetime | 68 | US 50 | 99.86 |
| Coronary Interventions and Diagnostics | Lifetime | 64 | US 32 | 99.77 |
| Medication Adherence and Compliance | Lifetime | 29 | US 22 | 99.22 |
| Cardiac pacing and defibrillation studies | Lifetime | 113 | US 60 | 99.56 |
| Cardiac Arrest and Resuscitation | Lifetime | 178 | US 100 | 99.39 |
| Peripheral Artery Disease Management | Lifetime | 134 | US 89 | 98.92 |
| Antiplatelet Therapy and Cardiovascular Diseases | Lifetime | 157 | US 67 | 99.17 |
| Cardiovascular Health and Risk Factors | Lifetime | 109 | US 62 | 98.23 |
| Chronic Disease Management Strategies | Lifetime | 234 | US 89 | 98.23 |
| Patient Satisfaction in Healthcare | Lifetime | 145 | US 98 | 98.18 |
| Clinical practice guidelines implementation | Lifetime | 188 | US 59 | 97.58 |
| Potassium and Related Disorders | Lifetime | 82 | US 52 | 98.08 |
| Blood Pressure and Hypertension Studies | Lifetime | 540 | US 220 | 98.45 |
| Healthcare Policy and Management | Lifetime | 437 | US 311 | 97.87 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 783 | US 302 | 98.19 |
| Mechanical Circulatory Support Devices | Lifetime | 516 | US 306 | 97.90 |
| Primary Care and Health Outcomes | Lifetime | 391 | US 228 | 97.81 |
| Cardiac Structural Anomalies and Repair | Lifetime | 666 | US 396 | 98.16 |
| Lipoproteins and Cardiovascular Health | Lifetime | 590 | US 274 | 97.60 |
| Cardiovascular Disease and Adiposity | Lifetime | 593 | US 291 | 97.12 |
| Acute Kidney Injury Research | Lifetime | 505 | US 208 | 95.33 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 454 | US 216 | 94.89 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 274 | US 70 | 94.84 |
| Healthcare cost, quality, practices | Lifetime | 483 | US 267 | 94.45 |
| Vascular Procedures and Complications | Lifetime | 864 | US 460 | 95.27 |
| Diagnosis and Treatment of Venous Diseases | Lifetime | 781 | US 277 | 91.72 |
| Heart rate and cardiovascular health | Lifetime | 185 | US 59 | 88.55 |
| Pain Management and Treatment | Lifetime | 732 | US 306 | 89.18 |
| Health Systems, Economic Evaluations, Quality of Life | 2021-2025 | 57 | US 16 | 99.03 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 64 | US 36 | 99.56 |
| Acute Myocardial Infarction Research | 2021-2025 | 45 | US 16 | 99.08 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 108 | US 38 | 98.99 |
| Heart Failure Treatment and Management | 2021-2025 | 67 | US 32 | 99.31 |
| Cardiac Health and Mental Health | 2021-2025 | 54 | US 22 | 97.27 |
| Cardiomyopathy and Myosin Studies | 2021-2025 | 71 | US 32 | 98.11 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 131 | US 52 | 98.29 |
| Coronary Interventions and Diagnostics | 2021-2025 | 130 | US 35 | 98.30 |
| Cardiac, Anesthesia and Surgical Outcomes | 2021-2025 | 282 | US 99 | 97.16 |
| Peripheral Artery Disease Management | 2021-2025 | 88 | US 46 | 96.71 |
| Medication Adherence and Compliance | 2021-2025 | 121 | US 50 | 91.62 |
| Diabetes Treatment and Management | 2021-2025 | 645 | US 216 | 93.46 |
| Trauma and Emergency Care Studies | 2021-2025 | 579 | US 244 | 90.54 |
| Cardiac Structural Anomalies and Repair | 2021-2025 | 946 | US 417 | 90.86 |
| Acute Kidney Injury Research | 2021-2025 | 572 | US 164 | 82.50 |
| Antiplatelet Therapy and Cardiovascular Diseases | 2021-2025 | 904 | US 178 | 83.29 |
| Potassium and Related Disorders | 2021-2025 | 263 | US 105 | 78.83 |
| Vascular Procedures and Complications | 2021-2025 | 833 | US 300 | 79.52 |
| Healthcare cost, quality, practices | 2021-2025 | 611 | US 258 | 76.35 |
| Patient Satisfaction in Healthcare | 2021-2025 | 921 | US 363 | 70.01 |
| Diagnosis and Treatment of Venous Diseases | 2021-2025 | 779 | US 244 | 68.68 |
